Year
2017
Abstract
Drugs supply chain is challenged by the growing value of the products, by the features of the products and by the expected levels of quality of service. But the stock-out question stays a topic in debate. The supply chain choices can partly explain this situation. Finally, new business models appear being able to change the nature of the distribution channels.
DORNIER, P.P. (2017). Désintégration et ré-engineering permanent de la Supply Chain de la Santé: le cas du médicament. Dans: Soigner ou vendre? Quel avenir pour la chaîne du médicament. 1st ed. Le Bord de l’Eau, pp. 115-132.